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Epigenomic map of human liver reveals principles
of zonated morphogenic and metabolic control
Mario Brosch1,2, Kathrin Kattler3, Alexander Herrmann1,2, Witigo von Schönfels4, Karl Nordström3,
Daniel Seehofer5, Georg Damm5, Thomas Becker4, Sebastian Zeissig1, Sophie Nehring1, Fabian Reichel1,
Vincent Moser 1, Raghavan Veera Thangapandi1, Felix Stickel6, Gustavo Baretton7, Christoph Röcken8,
Michael Muders7, Madlen Matz-Soja9, Michael Krawczak10, Gilles Gasparoni3, Hella Hartmann 11,
Andreas Dahl 2, Clemens Schafmayer4, Jörn Walter3 & Jochen Hampe 1,2
A deeper epigenomic understanding of spatial organization of cells in human tissues is an
important challenge. Here we report the ﬁrst combined positional analysis of transcriptomes
and methylomes across three micro-dissected zones (pericentral, intermediate and peri-
portal) of human liver. We identify pronounced anti-correlated transcriptional and methy-
lation gradients including a core of 271 genes controlling zonated metabolic and morphogen
networks and observe a prominent porto-central gradient of DNA methylation at binding
sites of 46 transcription factors. The gradient includes an epigenetic and transcriptional Wnt
signature supporting the concept of a pericentral hepatocyte regeneration pathway under
steady-state conditions. While donors with non-alcoholic fatty liver disease show consistent
gene expression differences corresponding to the severity of the disease across all zones, the
relative zonated gene expression and DNA methylation patterns remain unchanged. Overall
our data provide a wealth of new positional insights into zonal networks controlled by epi-
genetic and transcriptional gradients in human liver.
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T issues are composed of heterogeneous cell populations,each contributing to the overall performance of the bio-logical system. Within these populations, even morpholo-
gically similar cells of the same type may perform different
functions. Deciphering this cellular heterogeneity on a functional
level is key to understand tissue function and its alterations in
disease. Here, functional genomics may play an important role if
applied in a tissue context1, as combined transcriptional and
epigenetic analysis provides deep insights into functional state
and genomic programming of cells2–4. Such regionalized genomic
maps may be generated by single cell analysis of isolated cells and
subsequent mapping on tissue architecture using marker genes5,6
or by analysis of cells obtained directly from tissue context using
laser capture cryo microdissection (LCM). Advances in the
respective protocols allow the generation of transcriptomes7 and
reduced representation bisulﬁde sequencing (RRBS) methylomes8
from the 100 to 200 cells obtained typically by LCM. Such ana-
lysis could provide a combined epigenetic dataset, preserve tissue
context, avoid isolation procedures and may thus offer new
opportunities for the analysis of shock frozen human tissue.
Despite their rather uniform morphological appearance,
hepatocytes in mammalian liver are characterized by a hetero-
genous enzyme distribution along the porto-central axis9,10 which
is termed metabolic zonation11,12. Recently, using single cell
mRNA sequencing and spatial reconstruction, a global signature
of zonation in mouse liver has been established5. Immunohisto-
chemical analyses have conﬁrmed the zonal distribution of
metabolic enzymes, such as cytochrome P45013,14, alcohol
dehydrogenase15, fatty acid-binding protein16, glucose-6-
phosphatase and glutamine synthetase17 in human liver. Rele-
vant questions, such as the link of metabolic zonation to under-
lying morphogens, a global assessment of zonation and the
underlying regulatory mechanisms and not least also the relation
of rodent ﬁndings to human liver18 are as yet not fully
addressed19.
In an effort to contribute to a better understanding of these
problems, we generated a spatially resolved transcript and DNA
methylation map of human hepatocytes, demonstrate an epige-
netic zonation in human liver and provide pathway and tran-
scription factor signatures along the porto-central axis that help
to understand the underlying programs of liver metabolism,
regeneration and tissue structure.
Results
Laser microdissection of hepatic zones from human biopsies.
Hepatocytes were isolated by LCM from surgical liver samples
from 19 patients. Control liver samples (NC, N= 4) were
obtained from patients undergoing liver resection for metastasis
surgery or surgical liver biopsy for the exclusion of malignancy.
N= 15 liver samples were obtained from patients undergoing
bariatric surgery and were categorized based on standardized liver
histology employing the NAS score20 into phenotypic groups of
healthy obese (HO, N= 5), bland steatosis (STEA, N= 5) and
early non-alcoholic fatty liver disease (EARLY, N= 5). An
overview of the phenotypic characteristics of the patients is
provided in Table 1. Liver tissue was shock frozen directly in the
operating room ensuring ex vivo times of less than 40 s in all
cases. Hepatocytes were isolated by LCM from the pericentral,
intermediate and periportal areas of each patient from cryosec-
tions stained by cresyl violet (Fig. 1a, Supplementary Figure 1).
RNA quality and quantity was assessed with a Bioanalyzer
(Agilent, Santa Clara, CA) yielding a mean RIN of 8.09 and a
mean yield of 5.43 ng (Supplementary Figure 2A). Samples were
subjected to a modiﬁed SMART-Seq RNA sequencing
protocol7,21. Comparisons of the expression of indicator
transcripts from cell types, such as immune cells, endothelial cells
and ﬁbroblasts indicated an insigniﬁcant contamination by non-
parenchymal cells (Supplementary Figure 2B, C). Adjacent
cryosections were used to generate matching reduced repre-
sentation bisulﬁte sequencing (RRBS) data using the CpG
methylation insensitive restriction enzymes AluI and HaeIII to
cover ~14 million CpGs per sample8.
Signatures of transcriptional and epigenetic zonation. Principal
component analysis of the 1000 most variable transcripts (Fig. 1b)
revealed highly signiﬁcant correlations of PC1 and PC2 with
hepatic zones (PC1: r= 0.47, p= 2.0 × 10−4; PC2: r= 0.86, p <
2.2 × 10−16, Supplementary Figure 3) indicating zonation as a
major driver of variation between samples. Phenotypic group, sex,
age, BMI and diabetes state were used as covariates for paired
differential analysis using edgeR (FDR < 0.01, |log2FC| > 1). Using
the full dataset, we identiﬁed 317 genes predominantly expressed
in the pericentral zone and 488 genes with predominant peri-
portal expression (Supplementary Data 1). We did not observe
genes with highest expression in the intermediate zone, but rather
transcriptional gradients from pericentral to intermediate to
periportal zone or vice versa (Fig. 1c). Upon analysis of differ-
ential expression of steatotic samples (STEA, EARLY) versus
samples with normal liver histology (NC, HO), a signiﬁcant
deregulation of 467 genes was observed (Supplementary
Figure 4A, Supplementary Data 2), however largely irrespective of
hepatic zones (Supplementary Figures 4B, 5). If zonation analysis
was restricted to patients with normal liver histology (NC, HO),
reduced power led to the detection of only 470 zonated differ-
entially expressed genes (DEGs, Supplementary Data 3). Com-
parison of pairwise effect sizes between the analyses revealed
highly similar log2 fold changes (all p < 2.2 × 10−16) with pairwise
correlations (r2) ranging from 0.80 to 0.98 (Supplementary Fig-
ure 6) indicating that the transcriptional zonation signature is
persisting during early phases of NAFLD (Fig. 1b).
The transcriptional zonation of the mouse liver lobule has
recently been systematically studied from single cell transcrip-
tomic data deﬁning 9 zones5. For an interspecies orthologue
comparison of human and mouse data, we merged zones 1–2 of
the mouse for a comparison to our human pericentral data, the
mouse zones 4–5 to the intermediate zone and the mouse zones
8–9 to the periportal zone. We obtained a global transcript
correlation of r2= 0.77 (p < 2.2 × 10−16) in periportal and
pericentral zones and r2= 0.78 (p < 2.2 × 10−16) in the inter-
mediate zone (Supplementary Figure 7A-C) indicating an overall
Table 1 Summary of analyzed samples
Control
(NC)
Healthy
obese (HO)
Steatosis
(STEA)
Early NASH
(EARLY)
N 4 5 5 5
Male % 25 20 40 40
BMI 26
(22–27)
41 (32–47) 46 (32–62) 51 (40–60)
Age, years 57
(54–62)
36 (29–68) 46 (34–67) 44 (41–58)
Fat content, % 0 0 (0–5) 70 (35–90) 40 (40–50)
Inﬂammation 0 0 (0–1) 0 1 (1–1)
Fibrosis 0 0 0 (0–1) 0 (0–1)
Ballooning 0 0 0 0 (0–1)
NAS 0 0 3 (1–3) 3 (2–4)
The number of patients in each phenotypic category is provided together with demographic and
histologic characteristics. All numeric traits are shown as the median with the range provided in
parenthesis. BMI, body mass index; NAS, NAFLD activity score20
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Fig. 1 Transcriptional zonation along the porto-central axis. a Representative image of laser microdissection of pericentral (CV) and periportal (PV)
hepatocytes before LCM (upper images) and after LCM (lower images). b Principal component analysis of the 1000 most variable genes. Pericentral (PC)
is coloured in green, the intermediate zone (IZ) in red and periportal (PV) in blue. Symbols correspond to phenotypic groups. c Expression z-scores of
zonated genes at pericentral, intermediate and periportal zones (N= 19). Zonated genes (805) were determined using edgeR with |log2FC| > 1 and FDR <
0.01 between pericentral and periportal samples and clustered by correlation. The annotation legend displays controls (NC) in light blue, healthy obese
(HO) in dark blue, steatosis (STEA) in red and early NASH (EARLY) in orange. d Normalized expression (including standard deviation) of genes with
previously described zonation in mouse liver in human pericentral, intermediate and periportal zones. Dashed lines are for visualization only. e Normalized
expression (including standard deviation) of genes previously described as zonated in human liver in the CV, IZ and PV zones, based on
immunohistochemistry and in situ hybridization for GLUL, ALB17, EPHX, CYP1A222, CYP1A214 and FABP14. Dashed lines are for visualization only
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comparability of the datasets between species. Our zonation
comparison was restricted on 313 genes zonated in humans that
featured one to one matching orthologues with high conﬁdence
expression values in the mouse dataset. We detected 111 genes
with conserved zonation signatures between mouse and human
(Supplementary Data 4) including highly expressed zonation
landmark genes, such as GLUL, CYP2E1, SDS and APOF and
morphogens like LGR5 and SOX9 with low transcript levels
(Fig. 1d). However, 202 genes zonated in humans (e.g. Wnt
pathway members such as RSPO2) were not detected as zonated
in the mouse. Most non-corresponding genes in the mouse
showed a rather low expression level as compared to our deeply
sequenced human data (Supplementary Figure 7D). Comparison
of available immunohistochemistry (CYP1A2, EPHX1, EPHX2
and FABP) and in situ hybridization (ALB, CYP1A2) data from
strongly expressed human genes revealed a similar zonation
proﬁle14,16,17,22 (Fig. 1e).
On the epigenetic level, a principal component analysis
(Fig. 2a) of the 5000 most variable CpGs (coverage >5 in all
samples) showed a separation by hepatic zones with highly
signiﬁcant correlation of PC1 (p= 6.7 × 10−4, r= 0.44, Supple-
mentary Figure 4) and zonation. Following covariate adjustment,
a differential methylation analysis (see method for details)
between pericentral and periportal samples (MethylKit, CpG
coverage >10, 500 bp tiles, at least 3 CpGs, FDR adjusted p-value
<0.01) yielded 17,862 differentially methylated regions (DMRs)
with at least 5% methylation difference (Supplementary Data 5).
In contrast we identiﬁed only 23 signiﬁcant DMRs exhibiting the
highest methylation difference between PV or CV and IZ. The
vast majority of DMRs featured methylation gradients from
pericentral to intermediate to periportal zone (Fig. 2b). The
majority of DMRs was detected in gene context and only 18.7% of
DMRs were located in intergenic regions (Fig. 2c).
To integrate DNA methylation with expression changes, DMRs
were annotated to the closest gene transcriptional start site. 44.3%
(357) of zone-speciﬁc differentially expressed genes were
associated with zonal DMRs (1094). A total of 205 DEGs were
related with multiple DMRs. DMRs associated to differentially
expressed transcripts were predominantly located in introns
(46.4%), exons (18.7%) and promoter regions (24.7%, Fig. 2c).
DNA methylation differences of signiﬁcant DEG-associated
DMRs and corresponding expression changes (Fig. 2d) were
largely anti-correlated (p < 2.2 × 10−16, r2=−0.37). Ninety nine
DEGs associated with multiple DMRs displayed a combination of
hypo- and hypermethylated patterns of DMRs. We identiﬁed 132
upregulated genes associated with 430 hypomethylated DMRs in
the pericentral zone and 139 upregulated genes with 291
hypomethylated DMRs in the periportal zone. Based on this
clear anti-correlation between DNA methylation and expression
gradients, we deﬁne these 271 transcripts as epigenetically
marked driver genes of zonation (Supplementary Data 6). An
example of such potential epigenetically marked driver genes is
the Wnt signalling pathway member Palmitoleoyl-Protein
Carboxylesterase (NOTUM) containing a cluster of six hypo-
methylated promoter DMRs in the CV zone where the gene is
exclusively expressed. Publicly available DNaseI-seq and ChIP-
seq data from the hepatocyte-like cell line HepG2 (ENCODE)
identiﬁes potential regulatory activity for all seven DMRs
(Supplementary Figure 8).
DNA methylation control at transcription factor binding sites.
Tissue structure and zonation may be maintained not only by
external morphogen gradients, but also by differential signalling
efﬁcacy of transcription factors, that may even be uniformly
present along the porto-central axis: For instance, the hepatic
nuclear factor 4a (HNF4A) is a highly expressed transcription
factor (logCPM= 6.12 in our dataset) binding to promoters of
~12% of liver expressed genes23. How HNF4A exhibits is differ-
ential activity on zonated genes, such as cytochrome P450 and
aldehyde dehydrogenase genes23 remains unclear. Our RNAseq
data—in line with previous reports24—show that HNF4A
expression shows only a marginal trend towards zonation
(FDRPV_CV= 0.02, Log2FCPV_CV= –0.19). Still Hnf4a deletion in
mice leads to a clear zonal disruption of key metabolic enzymes25.
Our genome-wide DNA methylation data combined with the
ENCODE maps of transcription factor binding sites in HepG2
cells26, allowed us to assess a potential epigenetic layer of tran-
scription factor binding control: Indeed 46 of the 59 available
transcription factors showed an enrichment of differential
methylation at their mapped binding sites in the CV or PV zone
(Fig. 3a, p < 2.8 × 10−4, ﬁltering is described in Methods and TF’s
are listed in Supplementary Data 7). Because transcription factors
have different preferences for methylated and unmethylated
DNA27, Supplementary Data 8 summarizes the current literature
on binding properties of the analysed TFs combined with DNA
methylation in DEEP WGBS HepG2 data to aid interpretation of
the zonated TF binding site data. Most of the analyzed and dis-
cussed factors show a binding preference to unmethylated DNA.
HNF4A (nominal p= 4.7 × 10−300) binding sites showed the
most signiﬁcant methylation gradient along the porto-central
axis. This indicates that epigenetic control may elicit the zonated
activity of the otherwise uniformly present transcription factor.
The strongest effect size and a pericentral hypomethylation
(Δmethylation= 7%, p= 1.2 × 10−80) was observed for TCF7L2, the
key downstream transcription factor of the Wnt signalling
pathway28. Preferred binding of TCF7L2 at hypomethylated sites
indicates higher pericentral signalling efﬁciency (Supplementary
Data 8). An additional analysis using previously identiﬁed
TCF7L2 binding sites29 further supported our zonation results
(Supplementary Figure 9). TCF7L2 interacts with HNF4α in
multiple hepatocyte speciﬁc functions30. Like HNF4α, overall
TCF7L2 (FDRPV_CV= 0.008, Log2FCPV_CV= 0.3) shows only a
weak trend towards zonation. Because multiple TCF7L2 protein
products with differential activity have been reported31, we ana-
lyzed alternative splicing of TCF7L2 using the SALMON parallel
inference algorithm32. No zonation dependent alternative splicing
was detected (Supplementary Figure 10), thus indicating that
differential binding efﬁciency rather than transcript abundance
underlies the zonation of this factor. In order to provide a broader
assessment of zonated TF binding site methylation, we performed
an enrichment analysis using predicted TF sites (Supplementary
Data 9), which for instance also revealed a pericentral hypo-
methylation of HNF4A and TCF7L2 sites.
Zonated features of metabolic networks. Gene ontology over-
representation analysis both on the DEG and DMR datasets
(Supplementary Data 10, 11) recapitulated the proposed dis-
tribution of functional activities along the porto-central axis10.
We ﬁnd a clear enrichment of GO terms associated with meta-
bolism of steroids, cytochrome P450, xenobiotics or retinoic acid
in the pericentral area, glutathione and amino acid metabolism in
the periportal area (Fig. 3d). Metabolic zonation is also seen in the
GO analysis on the epigenetic level (Supplementary Data 4). A
consistent pattern of hypomethylation and overexpression for key
zonated metabolic enzymes (Supplementary Data 6) suggests that
they are epigenetically marked driver genes controlling zonated
regulatory pathways. In the pericentral area we ﬁnd a strong
expression and hypomethylation of CYP1A2 (logFC=−4.0, 12
DMRs: Δmeth 5.4–33.8%) and ALDH3A1 (logFC=−5.4, two
DMRs: Δmeth 6.3–19.3%). The location of these enzymes
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corresponds to the pericentral location of liver damage in alco-
holic liver disease and Paracetamol toxicity. Periportal candidate
epigenetically marked driver genes include glutaminase 2 (GLS2,
logFC= 3.0, 5 DMRs: Δmeth −15.1, −26.0%) and histidine
ammonia-lyase (HAL, logFC= 5.1, 3 DMRs: Δmeth −17.2,
−33.2%), which are relevant in the glutamate and amino acid
metabolism.
When assessing the underlying layer of transcriptional
regulation, strong zonation of DNA methylation of binding sites
of transcription factors of metabolic relevance (e.g. HNF4A and
HNF4G) was evident (Fig. 3a, Supplementary Data 7). Notably,
methylation of binding sites for Retinoid X receptor alpha
(RXRA), the heterodimeric partner for nuclear signalling of key
metabolic transcription factors PPARA, LXRA and FXR33, is
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strongly zonated (p= 6.4 × 10−298). Similar to HNF4A, RXRA
itself is highly expressed (Log2CPM= 6.22) and not zonated
(FDRPV_vs_CV= 0.97). The ensuing zonation of signalling efﬁcacy
of these transcription factors along the porto-central axis has
implications for ligands such as free fatty acids which play a key
role in the pathogenesis of non-alcoholic fatty liver disease
(NAFLD). Interestingly, FXR agonists compounds and drugs
such as signalling biliary acids (e.g. obeticholc acid34) might
therefore elicit a zonal therapeutic response, which may allow
targeting of the pharmacodynamic effect to the pericentral disease
location in NAFLD.
We also observed a signiﬁcant gradient of mitochondrial DNA
copies deduced from the ratio of mitochondrial reads in the
genomic coverage of RRBS data. There is signiﬁcantly less
mitochondrial DNA in the pericentral zone than in the
intermediate and periportal zone (p= 4.1 × 10−6, Fig. 3c). This
is in correspondence with a metabolic porto-central oxygen
gradient35.
Morphogen gradients and putative stem cell niche. The tran-
scriptional and epigenetic zonation includes a series of known
morphogen factors (Fig. 3d, Supplementary Data 9, 10). In the
periportal zone we ﬁnd an enrichment for Notch signaling
pathway related genes, while there was an enrichment of Wnt
signalling among the pericentrally upregulated genes (e.g.
GO:0016055, p= 5.7 × 10−4). A key role of Wnt signaling for the
maintenance of liver structure and regeneration is well established
from murine liver12,27–30. A recent analysis indicated that Wnt
pathways are also involved in human liver zonation19. Our deep
integrated datasets allowed a deeper look into the putative role of
pericentral Wnt signalling networks in human liver homoeostasis:
On both, the epigenetic and transcriptional level, we identify a
composed network of regulatory changes affecting selected
members of the pathway but not a global upregulation or acti-
vation (Fig. 4a). Prominent examples are the epigenetically
marked driver loci AXIN2 (ΔmethCV_PV= 5.0–29.3%), NOTUM
(ΔmethCV_PV= 10.7–36.5%), and LGR5 (ΔmethCV_PV= 9.2%). In
contrast, classical Wnt agonists such as WNT3A, WNT3 and
genes of the export machinery (e.g. porcupine, PORCN1 and
Wntless, WLS) are not zonally expressed, suggesting that the
pericentral WNT gradient in hepatocytes might not primarily be
regulated by them. Negative regulators of Wnt signaling such as
NOTUM, NKD1, RNF43 and ZNRF3 are upregulated 1 to 2 log
levels pericentrally creating a tightly controlled signalling envir-
onment around hepatocytes of this zone. The Wnt signalling
enhancers RSPO2, RSPO3 and LGR5 are expressed 2–7 log levels
higher pericentrally than periportally suggesting sensitization of
pericentral hepatocytes for canonical Wnt signals29. Interestingly,
LGR5 (logFC= 7.15, FDR= 4.88 × 10−26) shows the highest fold
change of all signiﬁcantly DEGs. Finally, binding sites of the main
Wnt-driven transcription factor (T-cell factor 7, TCF7L2, p=
1.22 × 10−80) in the liver28 are >5 fold pericentrally enriched
among the pericentral DMRs (Fig. 3b, c). We conclude that
morphogen gradients are controlled by multi-layered
transcriptional and epigenetic Wnt signalling signatures in the
zonated parenchyma.
The pericentral overexpression and hypomethylation of LGR5
(Fig. 4c) and AXIN2 (logFC= 2.24, FDR= 6.17 × 10−5, Fig. 4e) is
strongly correlated to the expression of the early liver progenitor
gene TBX3 (pairwise expression correlation to AXIN2: r2= 0.51,
p= 5.36 × 10−5 and LGR5: r2= 0.86, p < 2.2 × 10−16). TBX3 is
the transcript with the strongest zonation (logFCPV_CV= 2.26,
FDR= 4.1 × 10−59) and highest expression in the pericentral area
(Fig. 4d). TBX3 is embedded in a landscape of 11 pericentrally
hypomethylated DMRs (ΔmethCV_PV= 6.9–43.6%). Together
all our ﬁndings are consistent with the hypothesis that pericentral
AXIN2 and LGR5 positive cells36,37 are also in humans a source of
regeneration under steady-state conditions as reported from
murine lineage tracing experiments38.
Also on the periportal side, we identify epigenetically marked
driver genes such as the NOTCH ligand jagged 1 (JAG1, Fig. 4g)
(log2FC= 2.03, FDR= 1.64 × 10−5, ΔmethCV_PV=−5.3 to
10.0%)39 and ﬁnd a clear enrichment for a Notch GO term
(GO:0007219) associated with periportal DEGs (p= 1.68 × 10−4,
Fig. 4b). The liver stem cell marker EPCAM40–42 showed a
particularly strong periportal expression (log2FC= 5.42, FDR=
1.5 × 10−9, Fig. 4f) potentially marking the periportal hepatic
progenitor cell (HPC) niche39,43. Interestingly, pathways of other
liver-related morphogens such as FGF, TGF beta, HGF and BMP
are neither epigenetically nor transcriptionally zonated at an FDR
< 0.01 level, underlining the importance of the Wnt and Notch
pathways (Fig. 4h) for the maintenance of liver structure under
steady-state conditions.
Discussion
The systematic generation of reference epigenomes and tran-
scriptomes through the ENCODE and IHEC projects allows deep
insights into the functional state of isolated cells or tissues. The
integration of cell-speciﬁc epigenomic and transcriptomic proﬁles
with positional information appears as an essential next step to
better understand the organisation of organs and tissues and to
dissect regional program alterations in disease. Here, we present
the ﬁrst spatially resolved map of human hepatocyte genomic
architecture by integrating methylome and transcriptome data.
Previous human data is heterogenous and patchy and has used
either measurements of enzyme activities15,44,45 or immunohis-
tochemistry and in situ hybridization assays targeting whole-gene
families. We excluded the activity assays from our conﬁrmatory
comparisons in Fig. 1e, because enzyme activities reﬂect often
multiple transcripts, cofactor concentrations, phosphorylation
state and other confounders. While conﬁrming previous immu-
nohistochemical and gene expression studies14,16,17,19,22, we
identify hundreds of additionally zonated transcripts and observe
intriguing correlations between transcription and DNA-
methylation.
We optimized a pipeline starting from fast sampling in the
operating room, followed by a documented LCM on sectional
stains, which were directly used for the generation of genome
Fig. 2 Epigenetic zonation along the porto-central axis. a Principal component analysis of the 5000 most variable CpGs (coverage >5 in all samples).
Pericentral samples (CV) are coloured in green, the intermediate zone (IZ) in red and the periportal are (PV) in blue. Symbols refer to phenotypic group.
b Heatmap of methylation values of the top 1000 DMRs (CpG coverage >10, 500 bp tiles, at least 3 CpGs, FDR < 0.01) between pericentral and periportal
that were also covered in the intermediate zone (n= 19). Average CpG methylation differences between CV and PP range between 12.4% and 49.2%. Blue
corresponds to low and red to high average methylation values. The annotation legend displays lean controls (NC) in light blue, healthy obese (HO) in dark
blue, steatosis (STEA) in red and early NASH (EARLY) in orange. c Genomic annotation of all DMRs (upper pie plot) and of DEG-associated DMRs (lower
pie plot). d Visualization of gene expression (purple) and DNA methylation (dark red) z-scores of DEG-associated DMRs and corresponding genes at
pericentral (green), intermediate (red) and periportal zone (blue). In the Heatmap yellow corresponds to low z-scores (reduced expression or DNA
methylation) and navy to high z-scores (increased expression or DNA methylation)
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wide transcriptome and RRBS data8 from 100 to 200 captured
cells per section. This approach is complementary to the alter-
native single cell and FACS sorting approaches as it provides
greater sequencing depth and uses the pathological classiﬁcation
and direct zonal localisation within the tissue. Single cell
approaches on the other hand while providing a cleaner view on
cellular heterogeneity they have to rely on computational mod-
elling of their spatial position using independent molecular sig-
natures as anchor points. This highly informative single cell
modelling usually comes at the expense of sequencing depth and
gene coverage. We believe that our approach is an ideal com-
plementation to single cell approaches as it provides strong
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Fig. 4 Morphogen gradients and regulatory networks along the porto-central axis. a Expression z-scores of Wnt signalling pathway genes (GO:0016055,
GO:0090263, GO:0030178) show a gene-speciﬁc zonation signature. b Expression z-scores of Notch signalling pathway genes GO:0007219. c–g
Zonation proﬁle of transcripts for morphogens LGR5, AXIN2, TBX3, EPCAM and JAG1. The x-axis is the principal component 2, as a measure for zonation
(Note, for visualization reason the PCA2 axis was inverted). h Direct normalized gene expression (including standard deviation) of the morphogens
depicted in c–g dissected from the pericentral, intermediate and periportal zones. Dashed lines are for visualization only
Fig. 3 Transcription factor, mitochondrial and metabolic zonation along the porto-central axis. a Analysis of methylation of transcription factor binding sites
across zones. The y-axis depicts the normalized average methylation difference at binding sites overlapping with DMRs for the respective transcription
factor. The x-axis depicts the log10-fold enrichment of DMRs among binding sites. A detailed list and the analysis method are provided in Supplementary
Data 7. b Methylation of DMRs containing a transcription factor binding site for TCF7L2: Raw methylation data for all sites are shown for the CV and PV
regions. c Boxplot of the ratio of mitochondrial reads in reduced representation bisulﬁte sequencing data (n= 19) in pericentral (green), intermediate (red)
and periportal (blue) zone. Signiﬁcant differences (p < 0.001) are marked by asterisks. d Visualization of signiﬁcantly enriched GO terms (p < 0.05) of
zonally expressed genes. A negative GO term z-score corresponds to GO enrichment in the pericentral zone (green), a positive z-score to periportal
enrichment (blue). Circle size reﬂects the number of zonated genes relating to the term. Exemplary GO terms are labelled, while the full list of signiﬁcant
GO terms can be found in Supplementary Data 5
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sequencing depth, positional information and allows to compre-
hensively cover the epigenetic dimension.
Such positional datasets can be queried in multiple ways
offering a new and integrated approach of epigenetic and tran-
scriptional mechanisms controlling zonation, liver function and
morphogen control: First, we demonstrate for example, that
epigenetic zonation underlies the transcriptional porto-central
gradient and that anti-correlated DNA methylation and tran-
scription may deﬁne a set of potentially epigenetically marked
driver genes, that form a deeper layer underlying the zonation
gradients. Second, we propose that strongly zonated DNA-
methylation at transcription factor binding sites may form an
additional layer of epigenetic zonation control. Differential
methylation of binding sites may indicate a spatial activity of
otherwise uniformly expressed transcription factors, such as
HNF4A and RXR. Drugs targeting RXR (e.g. obeticolic acid) or its
interaction partner PPARα (i.e. ﬁbrates) are likely to pre-
ferentially affect target genes in pericentral hepatocytes, which
corresponds to the disease location of metabolic liver disease as a
zone 3 disorder20. Third, the integrated genomic dataset also
allows to assess the existing concepts on liver regeneration onto
the human steady-state situation: We demonstrate a strong
transcriptional and epigenetic gradient of Wnt signalling and
modulating factors. The pericentral expression of LGR5 and
AXIN2 and the corresponding gradient of the liver progenitor
marker TBX346,47 indicate a pericentral source of hepatocyte
regeneration38 under steady-state conditions in humans. Con-
versely, in the portal area, we observed a NOTCH and EPCAM
signature. This may correspond to hepatic progenitor cells at the
border to the biliary tree, which may form a relevant source of
regeneration under injury conditions36,39,48. Expansion of this
compartment clearly needs to be conﬁrmed in further studies
using cirrhotic human liver. In our dataset, we see that zonation
in both—the transcriptomic and epigenetic- dimensions is the by
far dominant signature and remains largely preserved in steatosis
and early NASH. This ﬁnding is compatible with the complete
regeneration and remodelling capacity of human liver in early
NAFLD.
In summary our study opens a new path for a functional
dissection of parenchymal differences in the liver lobule con-
necting positional information to known aspects of liver biology.
Many of the observations described will be helpful for a deeper
understanding of liver organ function in relation to disease.
Methods
Human liver samples. Liver samples were obtained intraoperatively in patients in
whom an intraoperative liver biopsy was indicated on clinical grounds such as
during scheduled liver resection, exclusion of liver malignancy during major
oncologic surgery, or assessment of liver histology during bariatric surgery. Stan-
dardized histology by a single pathologist (C.R.) employed the NAFLD activity
score (NAS)20. Samples were frozen immediately in liquid nitrogen ensuring an
ex vivo time of less than 40 s in all cases. Patients with evidence of viral hepatitis,
hemochromatosis or alcohol consumption >20 g per day for women and 30 g
per day for men were excluded. All patients provided written informed consent.
The study protocol was approved by the institutional review board (Ethikkom-
mission der Medizinischen Fakultät der Universität Kiel, D425/07, A111/99),
before study commencement.
Laser capture microdissection. The frozen tissue was cut in 20 µm slices and
mounted on precooled glass-slides. Immediately after mounting, the tissue was
ﬁxed by incubation in 70% EtOH for 2 min and stained by incubation in a cresyl
violet 50% EtOH solution for 30 s with two short subsequent wash steps in 70%
EtOH, followed by a 2 min air-drying step. All steps were performed on ice. In
sum, an area of 500,000 µm2, from of 5 to 10 periportal ﬁelds and intermediate
zones or hepatozytes surrounding 15–20 central veins per sample, was micro-
dissected using a ZEISS PALM MicroBeam LCM in Auto-LPC mode. Tissue pieces
for RRBS were frozen and maintained at −80 °C. Samples for RNA-Seq were
immediately processed.
RNA seq. After microdissection, RNA was isolated using the RNeasy Micro Kit
(Qiagen, Hilden, Germany). Concentration and RNA Quality were obtained by
using an Agilent BioAnalyzer (Agilent, Santa Clara, CA). The typical yield was
between 4.5 ng and a RIN between 8 and 9. The RNA was reverse transcribed and
ampliﬁed with the SMARTer Universal Low Input RNA Kit for Sequencing
(Takara, Clontech) and 1 ng of RNA. Libraries for next generation sequencing were
constructed with the Nextera DNA Library Prep Kit (Illumina, San Diego, Ca,
USA) and sequenced on a HiSeq2500 Sequencer.
RRBS. Reduced representation bisulﬁte sequencing (RRBS) of micro-dissected cells
was performed as previously described8 with modiﬁcations. Brieﬂy, cell lysis of
micro-dissected material was performed directly in the caps of the capturing tubes
by treatment with 8 µl lysis buffer (10 mM Tris-HCl, 5 mM EDTA) and 2 µl
proteinase K (1 mg per ml, NEB) at 55 °C for 3 h. For proteinase inactivation, 0.5 µl
Pefabloc (21 mM, Sigma) was added for 1 h at room temperature. Restriction was
performed using the CpG methylation insensitive enzymes HaeIII (25 U, NEB) and
AluI (5 U, NEB) supplemented with 1.5 µl CutSmart buffer (10X, NEB), 1 µl
MgAce (5 mM) and 1 µl yeast tRNA (100 ng) at 37 °C for 18 h. Enzymes were
inactivated at 80 °C for 20 min. A-Tailing was achieved with 1 µl Klenow Fragment
(3′ → 5′exo−, 5 U per µl, NEB) and 1 µl dATP (10 mM, NEB) at 37 °C for 30 min
followed by enzyme inactivation at 75 °C for 20min. Methylated Illumina TruSeq
sequencing adapters (adapter 1:ACACTCTTTCCCTACACGACGCTCTTCCGA
TCT, adapter 2:GATCGGAAGAGCAC ACGTCTGAACTCCAGTCAC) were ligated
using 1 µl pre-annealed adapters (100 µM), 0.5 µl T4 Ligase (2,000,000U per µl, NEB)
and 2 µl ATP (10mM, NEB) at 16 °C for 22 h. Subsequent bisulﬁte conversion was
performed using the EZ DNA Methylation Gold Kit (Zymo). Adapter ligated
fragments were ampliﬁed by PCR using 0.5 µl each of indexed TruSeq primers
(10 µM, Primer I5: AATGATACGGCGACCACCGAGATCTAC
AC[i5]ACACTCTTTC CCTACACGACGCTCTTCCGAT, Primer I7:GATCGGA
AGAGCACACGTCTGAACTC CAGTCAC[i7]ATCTCGTATGCCGTCTTCTG
CTTG), 3 µl PCR Buffer (10X, Qiagen), 1.2 µl MgCl2 (25 mM), 2.4 µl dNTPs
(10 mM) and 0.5 µl Hot Start Taq (5 U per µl, Qiagen) in a 30 µl reaction with
95 °C for 15 min, 22 cycles of 95 °C for 30 s, 60 °C for 30 s, 72 °C for 1 min and ﬁnal
elongation at 72 °C for 7 min. After puriﬁcation with 0.8 X Ampure XP Beads
(Beckman Coulter) libraries were sequenced on a HiSeq2500 (Illumina) using
TruSeq SBS Kit v3 – HS chemistry in a single read run with 90 bp read length.
Data processing. Reads were trimmed with Trim Galore! (v0.4.2) http://www.
bioinformatics.babraham.ac.uk/projects/trim_galore/) for adapter contamination
and 3′-ends with base quality below 20. RRBS reads were trimmed in RRBS mode.
The reads were then aligned to the 1000 genomes version of the human GRCh37
reference and further processed as described below. RRBS reads were aligned with
the BWA (v0.6.2)49 wrapper methylCtools (v0.9.2)50. Samtools (v1.3)51 and Picard
tools (v1.115) (http://broadinstitute.github.io/picard/) was utilized for converting,
merging and indexing of alignment ﬁles. Bis-SNP was used for SNP (dbSNP, v138,
http://www.ncbi.nlm.nih.gov/SNP) aware realignment, quality recalibration and
methylation calls. Differentially methylated sites were detected using MethylKit
(v1.3.1)52 with adjustment for the potential confounders phenotype, sex, age, BMI,
donor and the prevalence of diabetes (Supplementary Fig. 3). The tool was mod-
iﬁed to treat missing sites as zero-covered sites in the aggregation step of the tiled
analysis. After merging both strands the calls were ﬁltered to sites with at least 10X
coverage. We searched for differentially methylated 500 bp tiles (step-size: 500 bp)
with at least 3 CpGs, a maximum q-value of 0.01 and minimal methylation dif-
ference of 5%. Mitochondria, X and Y chromosomes were excluded. The resulting
DMRs were annotated to closest genes and genomic features (promoter, exon,
intron or intergenic) using Gencode gene models (v19)53 with the help of bedtools
(v2.20.1)54.
RNA-seq reads were aligned with the STAR (v2.5.2a)55 and the per sample 2-
pass mapping strategy processing all reads in both passes as described in the
documentation. Read counts were summarized to Gencode gene models (v19)53
with featureCounts (v1.5.0-p3)56 counting primary alignments only. EdgeR
(v3.16.5) was used to detect differentially expressed genes with maximal q-value of
0.01 and minimal absolute logFC of 1. We discarded genes for which fewer than
ﬁve samples had a counts per million value above 0.5, calculated normalization
factors and robustly estimated the dispersion. In our default setting we used a
model adjusting for phenotype, sex, age, BMI, donor and the prevalence of diabetes
(Supplementary Figure 3).
Integrative analysis and visualization. For interspecies comparisons, recon-
structed mouse zones 1 and 2 were considered as pericentral, zones 4 and 5 as
intermediate and zones 8 and 9 as periportal. Spearman rank statistics of
sequencing depth normalized mRNA expression levels (log(CPM+ 1)) were cal-
culated for mouse single cell data5 and human LCM-RNAseq data with one-to-one
matching orthologs. The zonation comparison was restricted to genes with high
conﬁdence expression values corresponding to a CPM > 0 in the mouse dataset
after background subtraction as previously described5. For visualization of
exemplary genes across the three zones, expression data were normalized to the
zone with the highest expression for each individual gene. Potential epigenetically
controlled driver genes were deﬁned as upregulated genes that also featured at least
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one hypomethylated DMR annotated to the gene. Genomic tracks of expression
and methylation data (bigwig) were generated using bedtools54 and UCSC tools57
and visualized in the IGV browser58. GO term enrichment analysis of DEGs and
DMR associated genes was performed with DAVID59 and signiﬁcant DEG GO
terms (p < 0.05) were visualized using GOplot60.
For analysis of methylation of transcription factor binding sites with available
information of the hepatocyte cell line HepG2 in ENCODE (V3), a 2 × 2 table was
constructed for each transcription factor as follows: The 196,621 methylation
regions (500 bp intervals), were categorized in regions with and without binding
sites for the respective transcription factor and by differential methylation between
the CV and PV zones as analysed in the main DMR analysis (Supplementary
Data 6) yielding four categories (noDMR.noTFBS, noDMR.TFBS, DMR.noTFBS
and DMR.TFBS). Deviation from the null hypothesis (i.e. equal distribution of
binding sites between DMR and regions without differential methylation) was
tested by Fisher's exact test. The methylation gradient between CV and PV for
intervals without and with binding sites for the respective transcription factors
yields the zonated methylation difference Delta.TXF. Because all DMRs show a
mild porto-central demethylation gradient and this gradient is reﬂected in DMRs
with transcription factor binding sites, the zonated differential methylation is
normalized to the mean of Delta.TXF (−1.27%) for the ﬁnal normalized Delta.
TXF.Norm.
Data availability
The data generated in this study is available at the NCBI Gene Expression Omnibus
(GEO) (http://www.ncbi.nlm.nih.gov/geo) under identiﬁer GSE105127.
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